intravenous injection of mesenchymal stem cells

BIOLOGICAL2 trials

Sponsors

Jichi Medical University, Department of Medicine, Division of Hematology, Royan Institute

Conditions

Multiple Sclerosisrefractoty acute GVHD after stem cell transplantation

Phase 1

Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis

CompletedNCT01377870

Royan InstituteMultiple Sclerosis

Start: 2011-12-31End: 2014-04-30Updated: 2018-03-07

Unknown Phase

Efficacy of mesenchymal stem cells for treatment of refractory acute GVHD after stem cell transplantation

Active, not recruitingJPRN-C000000423

Jichi Medical University, Department of Medicine, Division of Hematologyrefractoty acute GVHD after stem cell transplantation

Start: 2006-06-01Target: 5Updated: 2026-06-29